Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer-Reference-Cited by-同舟云学术

Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer

Published:2020-05-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rizzuto Ivana¹,Otter Sophie J²,Bharathan Rasiah³,Stewart Alexandra²

Affiliation:

1. Department of Gynaecological Oncology; Royal Brisbane and Women’s Hospital; Brisbane Australia

2. Oncology; Royal Surrey County Hospital; Guildford UK

3. Department of Gynaecological Oncology; University Hospitals of Leicester NHS Trust, Leicester General Hospital; Leicester UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference80 articles.

1. Clinical trials of antiangiogenesis therapy in recurrent/persistent and metastatic cervical cancer;Alldredge;Oncologist,2016

2. Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease;Bellone;Gynecologic Oncology,2007

3. FIGO Cancer report 2018;Denny;International Journal of Gynaecology and Obstetrics,2019

4. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy;Borgstrom;Cancer Research,1996

5. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumours in vivo;Borgstrom;Prostate,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer;Medical Oncology;2024-07-10

2. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer;Cancer Biology & Therapy;2024-05-13

3. Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers;Future Pharmacology;2023-06-01